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Abstract 
Angiotensin II (All) was found to upregulate tissue inhibitor of metalloproteineses-1 (TIMP-1) gene expression in rat heart endothelial 
cells in a dose and time-dependent manner. The maximal stimulation of TIMP-1 mRNA was achieved by 2 h after the addition of All. 
This effect was blocked by losartan, an AT1 receptor antagonist and by calphostin C, a protein kinase C inhibitor. Addition of 
cycloheximide superinduced and actinomycin D abolished the induction. These results suggest that All stimulates TIMP-1 production by 
a protein kinase C dependent pathway which is dependent upon de novo RNA synthesis, lmmunoprecipitation experiment showed an 
enhanced band of 28 kDa from the conditioned medium of All-treated cultures. Immunoblot analysis revealed that TIMP-I was detectable 
in the conditioned medium 4 h after All stimulation. Since endothelial cells line the blood vessels and sense the rise in All associated 
with hypertension, the TIMP-1 released by these cells may provide an initial trigger leading to cardiac fibrosis in angiotensin-renin 
dependent hypertension. 
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1. Introduct ion 
The primary purpose of this study is to examine the 
cellular and molecular basis that leads to cardiac fibrosis in 
renin-angiotensin dependent hypertension. The progression 
of the fibrolytic process generally begins in the adventitia 
of intramyocardial arterie,; and subsequently extends into 
the interstitial space [1]. In order to study the initiating 
events contributing to the overall balance of collagen 
metabolism in the perivascular fibrosis, endothelial cells 
derived from rat hearts were utilized as an in vitro model. 
The objective is to examine the role of nonmuscle cells in 
the modulation of collagen metabolism in response to 
angiotensin II (All). 
Matrix metalloproteina,;es are a family of Zn-containing 
enzymes responsible for the degradation of most matrix 
components [2-4]. These enzymes play important roles in 
inflammation, repair, and 1tissue remodelling. The activities 
of these metalloproteinases are partly controlled by the 
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natural inhibitors-tissue inhibitors of metalloproteinases 
(TIMP) [5]. TIMP-1 was first described by Stricklin and 
Welgus [6]. It is a 28 kDa glycoprotein which binds to 
active metalloproteinases in 1:1 stoichiometry. TIMP- 1 
was shown to have sequence homology with erythropoitin 
potentiating activity [7]. Various cell types have been 
shown to express TIMP-1 including fibroblasts [8,9], 
monocytes or macrophages [10], and chondrocytes [11]. In 
addition, several endothelial cell types have been known to 
secrete TIMP- 1 constitutively [ 12,13]. Recently other TIMP 
family (TIMP-2, TIMP-3) have been cloned [14-17]. 
The expression of TIMP-1 in various cell types is 
stimulated by a number of agents such as epidermal growth 
factor, basic fibroblast growth factor, transforming growth 
factor-r,  phorbol ester [9,18], interleukin 1 [8], interleukin 
6 [11], interleukin 11 [19], TNF-a:  [20], oncostatin M [21], 
retinols [22], and dexamethasone [23]. 
Since circulating AII is known to increase in renovascu- 
lar hypertension, we explored the action of All on the 
expression of TIMP-1 in rat heart endothelial cells. In this 
study we present evidence that the vasoconstrictor AII is a 
potent inducer of TIMP-1 in these cells. The physiological 
significance of our findings is discussed. 
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2. Materials and methods 
2.1. Cell culture 
Rat heart endothelial cells (RHE) were prepared accord- 
ing to Diglio et al. [24]. Cells were cultured in Dulbecco's 
modified Eagle's medium (DMEM, Gibco) containing 10% 
fetal bovine serum (FBS, Biofluids), 2 mM L-glutamine 
and 25 /zg/ml gentamycin at 37°C in a humidified atmo- 
sphere of 5% CO 2. Cells were serially subcultured by 
treatment with trypsin (0.05% trypsin-0.5 mM Versene, pH 
7.4) and used for experimentation between passages 10 
and 25. These cells showed contact inhibition and typical 
'cobblestone' morphology, lmmunofluorescence studies 
showed positive staining for factor VIII and negative for 
a-actin. 
2.2. Northern blot analysis 
Cells were seeded into 100 mm dishes containing 
DMEM and 10% FBS. Near confluent cells were changed 
to serum-free DMEM supplemented with ITS (1 /~M 
insulin, 6.25 /xg/ml transferrin and 6.25 ng/ml  selenous 
acid) for 24 h before the addition of testing agents. Total 
RNA was extracted using the acid guanidinium thio- 
cyanate-phenol-CHC13 extraction [25]. Fifteen /zg of RNA 
was denatured and separated by electrophoresis on 1% 
agarose gel containing 2.2 M formaldehyde. RNA ladder 
(BRL) was included as size marker. Following transfer the 
RNA was covalently bound to Gene Screen (DuPont-New 
England Nuclear) by UV-crosslinking. Hybridization and 
washing conditions were carried out according to the 
method of Church and Gilbert [26]. Mouse TIMP-1 cDNA 
probe [27] was generously provided by Dr. Mark D. 
Johnson, Northwestern University. The cDNAs were la- 
beled with [32p]dCTP using random primer synthesis 
(Amersham). The blots were exposed to XAR films with 
an intensifying screen. The intensity of the bands was 
quantitated by Ambis Image Analysis System. Each exper- 
iment was routinely performed three to four times and 
consistent results were obtained. 
with ITS (1 /~M insulin, 6.25 /xg/m transferrin and 6.25 
ng/ml  selenous acid). The medium was replaced with 1 
ml methionine-free DMEM containing 100 /.tCi 
[35S]methionine (DuPont-New England Nuclear) in the 
absence or presence of AII (1.  10 -7 M). Cells were 
labeled at 37°C for 16 h. Control and AII-treated media 
containing the same amount of radioactivity was immuno- 
precipitated with rabbit anti-human TIMP-1 antibody. The 
immunoprecipitates were washed as previously described 
and displayed on a 10% SDS-PAGE [29]. 
2.5. lmmunoblot analysis of  T1MP-1 
Near confluent RHE cultures in 100 mm dishes were 
incubated with 5 ml serum-free DMEM supplemented with 
ITS (1 ELM insulin, 6,25 /xg/ml transferrin and 6.25 
ng/ml  selenous acid). Cells were treated with or without 
AII for designated times. Secreted proteins were precipi- 
tated from the medium with quinine sulfate-SDS according 
to the method of Werb et al. [30]. The precipitates were 
washed with 80% acetone and resuspended in Laemmli gel 
sample buffer. The proteins were electrophoresed on 8% 
SDS-PAGE. lmmunoblots were carried out with rabbit 
anti-human TIMP-l antibody (1:250) at room temperature 
for 2 h and then with goat anti-rabbit IgG conjugated to 
alkaline phosphatase (1:10 000, Sigma Chemical Co.) for 2 
h. Color reaction was performed with nitroblue tetrazolium 
and 5-bromo-4-chloro-3-indolyl phosphate. 
2.6. Chemicals 
Angiotensin II was a gift from Ciba Pharmaceutical 
Co., Division of Ciba-Geygi Corp. Losartan (DuP 753) and 
PD 123319 were provided by E.I. Dupont de Nemours and 
Company and Parke-Davis Pharmaceutical Research Divi- 
sion, Warner-Lambert Company, respectively. Calphostin 
C, H7, and GFI09203X were obtained from Calbiochem, 
Sigma, and Biomol Research Laboratories, Inc., respec- 
tively. All other molecular biology reagents were of the 
highest grade available from Promega. 
2.3. Preparation of TIMP-1 polyclonal antibody 3. Results 
Human T1MP-1 was kindly provided by Synergen Cor- 
poration (Denver, CO). An aliquot of 100 /zg TIMP-1 was 
emulsified with an equal volume of Freund's complete 
adjuvant and injected s.c. into rabbits at multiple sites. 
Booster injections of 50 /xg were given every 2 wk. The 
specificity of the antibody was checked by Western blot 
analysis [28]. 
2.4. Immunoprecipitation of TIMP-1 
Near confluent RHE cultures in 35 mm dishes were 
incubated overnight with serum-free DMEM supplemented 
Rat heart endothelial cultures were arrested by serum- 
starvation for 24 h to avoid interference of serum compo- 
nents. Steady-state levels of TIMP-1 mRNA was deter- 
mined in RHE cultures by Northern blot analysis. Basal 
level of the TIMP-1 mRNA (1 kb) was low and its level 
increased rapidly upon the addition of AII. Levels were 
increased 5-fold at 2 h (Fig. 1, lane 4) and then declined 
over 6 h (lane 8). The next series of experiments were 
carried out in RHE cultures treated with a wide range of 
All doses (1 • 10 -11 M-1 • 10  - 6  M )  for 2 h. Fig. 2 shows 
that the optimal induction was obtained with 1 • 10  - 7  M 
AII (lane 6). 
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Fig. 1. Time-course of T1MP-1 mRNA induction in RHE by All. Near 
confluent RHE cultures were exposed to 1.10 -7 M All for the times 
indicated. 15 /xg of total RNA was hybridized with a mouse TIMP-1 
cDNA probe (top panel). The staining pattern of 28 S and 18 S ribosomal 
RNAs is shown in the bottom panel. Hybridization patterns of cells 
treated with All for 0 rain (lane 1); 30 min (lane 2); 1 h (lane 3); 2 h 
(lane 4); 3 h (lane 5); 4 h (lane 6); 5 h (lane 7); 6 h (lane 8); are shown. 
Figure shown is a representation of three independent experiments. 
In order to examine the mechanism of TIMP-1 mRNA 
induction, inhibitors of protein and RNA synthesis were 
included singly or in combination with All. Cycloheximide 
alone induced TIMP-1 mRNA (Fig. 3, lane 3). In the 
presence of All and cycloheximide the induction was 
higher than All alone (lane 4), implying that the induction 
does not require de novo protein synthesis. Addition of 
actinomycin D abolished tile induction (lane 6), indicating 
that de novo RNA synthesits is required. 
Losartan (DuP 753), a specific antagonist for type I 
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Fig. 3. Effect of cycloheximide (CHX) and actinomycin D (Act D) on the 
induction of TIMP-1 mRNA by All. Near confluent cultures of RHE 
were treated with AII for 2 h in the absence or presence of CI-IX (20 
/xg/ml) or Act D (1 /xg/ml). Fifteen /xg of total RNA was hybridized 
with a mouse TIMP-I cDNA probe. Hybridization patterns of control 
cells (lane 1); cells treated with 1.10 -7 M All (lane 2); CHX (lane 3); 
All and CHX (lane 4); Act D (lane 5); AII and Act D (lane 6); are shown. 
receptors of AII [31] was included to examine if the effect 
of All is mediated by type I receptors. In the presence of 
1 • 10 -6  M losartan, the induction of TIMP-1 mRNA was 
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Fig. 2. Induction of TIMP-1 mRNA as a function of AII dose. Near 
confluent cultures of RHE were treated with 1 • 10 "jj M to 1 • 106 M of 
All for 2 h. 15 /xg of total RNA was hybridized with a cDNA probe for 
mouse TIMP-1 (top panel). The hybridization patterns of control cells 
(lane 1), cells treated with 1 • 10 "ll M All (lane 2); 1.10 -1° M All (lane 
3); 1.10 -9 M AII (lane 4); 1.10 -3 M AII (lane 5); 1.10 -7 MAII  (lane 6); 
1 • 10 -6 M All (lane 7); are shown. 
28S 
18S 
Fig. 4. Effect of losartan and PD 123319 on the induction of TIMP-1 
mRNA by AII. Total RNA was isolated from RHE cultures in the 
absence or presence of test agent(s) for 2 h as indicated. Hybridization 
patterns of control ceils (lane 1); cells treated with 1 • 10 -7 M A I I  (lane 
2); 1.10 -6 M losartan (lane 3); All and losartan (lane 4); 1.10 -6 M PD 
123319 (lane 5); AII and PD 123319 (lane 6); are shown. 
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Fig. 5. Effect of protein kinase C inhibitors, calphostin C, H7, and GF109203X, on the induction of TIMP-1 mRNA by All. Near confluent RHE cultures 
were pretreated with calphostin C (0.05 /zM), H7 (1 /xM) or GF109203X (I /zM) for 30 min before the addition of All for 2 h. Panel A shows the 
hybridization pattern of control cells (lane 1); cells treated with AII (lane 2); 0 .05/zM calphostin C (lane 3); All and calphostin C (lane 4). Panel B shows 
the hybridization pattern of control cells (lane 1); All (lane 2); 1 /zM H7 (lane 3); All and H7 (lane 4); 1 /~M GFI09203X (lane 5); All and GF109203X 
(lane 6). 
abolished (Fig. 4, lane 4), indicating that the induction of 
TIMP-1 mRNA by AII was mediated by type I receptors. 
In order to examine the involvement of type II receptors of 
All, PD 123319 was included [32]. PD 123319 at a 
concentration of 1 • 10 - 6  M did not abolish the induction 
of TIMP-1 mRNA (Fig. 4, lane 6). 
To study if the induction of TIMP-1 mRNA involves a 
protein kinase C dependent pathway, calphostin C [33] a 
protein kinase C inhibitor, was included. For these experi- 
ments RHE cultures were pretreated with 0.05 /zM 
calphostin C for 30 min prior to the addition of All for 2 h. 
Calphostin C was able to block the induction of T1MP-1 
mRNA (Fig. 5A, lane 4). Other protein kinase C inhibitors, 
such as H7 [34] and GF 109203X [35], were also tested 
and similar results were obtained (Fig. 5B, lanes 4 and 6). 
Our results suggest that the effect of All is mediated by a 
protein kinase C dependent pathway. 
Immunoprecipitation experiments were carried out with 
[35S]methionine labeled cells to study the biosynthesis of 
TIMP-I in the absence or presence of All. Conditioned 
medium from AII-treated RHE cultures contained a protein 
of M r 28 kDa molecular mass upon precipitation with 
TIMP-1 antibody (Fig. 6, lane 4). This protein was absent 
when AII-stimulated conditioned medium was immuno- 
precipitated with preimmune serum (lane 3). A faint band 
of TIMP-1 could be detected when the control medium 
was immunoprecipitated with TIMP-1 antibody (lane 2). 
The appearance of TIMP-1 in the conditioned medium 
of AII-stimulated RHE cultures was examined by im- 
munoblot analysis. In the absence of All stimulation, RHE 
cells did not secrete any detectable amount of TIMP-1 
(Fig. 7, lane 1). A band of M r 28 kDa TIMP-1 appeared in 
the medium 4 h after AII-stimulation (lane 4). The level of 
TIMP-1 increased as time progressed from 6 h to 12 h 
(lanes 5-7). After 24 h, the basal level of TIMP-1 was 
elevated possibly due to the accumulation of growth fac- 
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Fig. 6. AII enhanced the synthesis of  TIMP-1. Near confluent RHE 
cultures were incubated overnight with serum-free DMEM supplemented 
with ITS. The medium was replaced with methionine-free-DMEM con- 
taining 100 /zCi /ml  [35S]methionine in the presence or absence of All 
(1-10 -7 M). Cells were labeled at 37°C for 16 h. Immunoprecipitation 
with rabbit anti-human TIMP1 antibody was carried out as described in 
Section 2. Immunoprecipitates were displayed on 10% SDS-PAGE. Lanes 
1 and 3 show the fluorogram of control and All-treated medium immuno- 
precipitated with preimmunne serum, lanes 2 and 4 show the pattern from 
control and AlI-treated medium immunoprecipitated with TIMP-1 anti- 
serum. 
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Fig. 7. Appearance of TIMP-1 in the conditioned medium. Near confluent RHE cultures were treated with or without All for different times. Secreted 
proteins were precipitated with quinine sulfate-SDS and separated on 8% SDS-PAGE. Immunoblot with human TIMP-I antibody was carried out as 
described in Section 2. 
tors and cytokines in the conditioned medium (results not 
shown). 
4. Discussion 
In this study we found that vasoconstrictor AII could 
induce TIMP-1 in rat heart endothelial cells in a dose and 
time dependent manner. The induction requires RNA syn- 
thesis. Furthermore the induction appears to be mediated 
by type I receptors of  All and is dependent on protein 
kinase C pathway. 
It is interesting to note that the level of TIMP-I mRNA 
in the presence of  cycloheximide alone is higher than the 
basal level. In addition, TIMP-1 mRNA is superinduced in 
the presence of  cycloheximide and All. Cycloheximide 
might inhibit the synthesis of  RNases which are involved 
in the degradation of TIMP-1 mRNA. The increase in 
TIMP-1 mRNA correlated well with the appearance of  
TIMP-I in the conditioned medium. Upregulation of  
TIMP- 1 mRNA peaked at 2 h after All stimulation, whereas 
TIMP-1 release was detectable 4 h after the addition of 
AII. 
Our data demonstrated that the induction of  TIMP-1 
mRNA could be mainly attributed to transcriptional activa- 
tion via protein kinase C pathway. The elements responsi- 
ble for this activation are not characterized in the present 
study. TIMP-1 promoter and its regulatory elements have 
been studied by a number of investigators [36-38]. The 
promoter of the TIMP-1 gene contains AP-1 sites which 
can modulate gene expression. In addition, All induced the 
expression of  transcription factors c-fos and c-jun in RHE 
cells (data not shown). These proteins form an AP-I  
complex which activates gene transcription. Whether the 
effect of  All  is mediated by the AP-1 element in our cell 
system is under investigation. 
We reported previously that AII could induce TGF-/3 1 
mRNA in RHE cells [39]. TGF- f l  1 has been shown in 
several studies to upregulate the expression of  TIMP-1 in 
human fibroblasts [9] and rat bone cells [40]. The induction 
of TIMP- 1 by AII observed in the present study could be a 
direct effect or is secondary to the effect of  TGF-fl I 
induction. Two lines of  evidence tend to favor the first 
possibility. First of all, the TGF-fl 1 secreted into the 
conditioned medium was in a latent form as demonstrated 
by the bioactivity assays [39]. Secondly, the kinetics of  
mRNA induction for TGF-/31 and TIMP-I are quite differ- 
ent. The optimal induction of  TGF-/31 mRNA was achieved 
6 h after the addition of AII whereas TIMP-1 message 
level was maximally induced 2 h after AII stimulation. 
Previously, we reported that AII induced both TGF-fl 1 
and endothelin-1 message levels in RHE cultures [39,41]. 
These factors could be utilized by neighboring fibroblasts 
or smooth muscle cells for the production of  extracellular 
matrix [42,43]. The interplay of  AII, TIMP-1, and other 
humoral factors such as TGF-/31 and endothelin-1 is im- 
plicated in the fibrosis of the cardiovascular system. 
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